Market
BSE Prices delayed by 5 minutes... << Prices as on Mar 09, 2026 - 3:59PM >>  ABB India  5991.5 [ -1.23% ] ACC  1451.6 [ -3.31% ] Ambuja Cements  452.4 [ -3.06% ] Asian Paints  2217 [ -2.75% ] Axis Bank  1288.35 [ -2.09% ] Bajaj Auto  9379.15 [ -4.42% ] Bank of Baroda  288.15 [ -2.40% ] Bharti Airtel  1867.15 [ -0.23% ] Bharat Heavy  255.3 [ -1.39% ] Bharat Petroleum  331.1 [ -6.12% ] Britannia Industries  5881.9 [ -1.73% ] Cipla  1320 [ -0.13% ] Coal India  437.7 [ -0.61% ] Colgate Palm  2161.4 [ -1.91% ] Dabur India  465.05 [ -2.89% ] DLF  574.7 [ -0.57% ] Dr. Reddy's Lab.  1283.5 [ -1.56% ] GAIL (India)  148.9 [ -4.31% ] Grasim Industries  2671.3 [ -1.67% ] HCL Technologies  1358.6 [ 0.13% ] HDFC Bank  839.2 [ -2.09% ] Hero MotoCorp  5455 [ -0.97% ] Hindustan Unilever  2194 [ -1.44% ] Hindalco Industries  945.5 [ -1.37% ] ICICI Bank  1277.4 [ -2.74% ] Indian Hotels Co.  611.8 [ -1.91% ] IndusInd Bank  883 [ -3.68% ] Infosys  1314.35 [ 0.47% ] ITC  306.1 [ -1.18% ] Jindal Steel  1148 [ -2.71% ] Kotak Mahindra Bank  386.05 [ -3.48% ] L&T  3840 [ -2.76% ] Lupin  2300 [ -1.90% ] Mahi. & Mahi  3187.25 [ -4.39% ] Maruti Suzuki India  13487.25 [ -4.68% ] MTNL  25.44 [ -5.95% ] Nestle India  1236.2 [ -1.29% ] NIIT  62.45 [ -4.42% ] NMDC  79.18 [ -0.59% ] NTPC  376.45 [ -1.05% ] ONGC  270.05 [ -3.17% ] Punj. NationlBak  115.2 [ -3.44% ] Power Grid Corpn.  295.25 [ -1.32% ] Reliance Industries  1424.45 [ 1.37% ] SBI  1098.7 [ -3.92% ] Vedanta  709.3 [ -1.65% ] Shipping Corpn.  233.6 [ -2.93% ] Sun Pharmaceutical  1807.6 [ 0.48% ] Tata Chemicals  697.4 [ -1.39% ] Tata Consumer Produc  1097.25 [ -1.75% ] Tata Motors Passenge  331.95 [ -5.35% ] Tata Steel  191.05 [ -3.75% ] Tata Power Co.  372.9 [ -0.68% ] Tata Consult. Serv.  2527.7 [ -1.17% ] Tech Mahindra  1335.5 [ 0.26% ] UltraTech Cement  11360 [ -5.23% ] United Spirits  1353.4 [ -2.46% ] Wipro  198.6 [ 1.59% ] Zee Entertainment  79.94 [ -2.30% ] 
Gland Pharma Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 27637.89 Cr. P/BV 2.81 Book Value (Rs.) 596.28
52 Week High/Low (Rs.) 2131/1278 FV/ML 1/1 P/E(X) 39.57
Bookclosure 14/08/2025 EPS (Rs.) 42.40 Div Yield (%) 0.00
Year End :2025-03 

To The Members of Gland Pharma Limited

Report on the Audit of the Standalone FinancialStatementsOpinion

We have audited the accompanying standalone financial statements of Gland Pharma Limited (the “Company"), which comprise the Balance Sheet as at March 31, 2025, and the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Changes in Equity and the Statement of Cash Flows for the year ended on that date, and notes to the standalone financial statements, including a summary of material accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 (the “Act") in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards prescribed under Section 133 of the Act, (“Ind AS") and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2025, and its profit, total comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial statements in accordance with the Standards on Auditing (“SA"s) specified under Section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor's Responsibility for the Audit of the Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (“ICAI") together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current period. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. We have determined the matters described below to be the key audit matters to be communicated in our report.

Sr.

No.

Key Audit Matter

Auditor's Response

1

Revenue from Sale of goods (Refer note 2.1(e) of the Standalone Financial Statements)

The Company recognises revenue from sale of goods based on the terms and conditions of the agreements/arrangements, which vary with different customers.

For sale transactions in a certain period around the Balance Sheet date, it is essential to ensure whether the transfer of control of the goods by the Company to the customer occurs before the Balance Sheet date.

Considering material sale transactions close to the year end and that revenue recognition is subject to transfer of control to the customers before the Balance Sheet date, we consider the risk of revenue from sale of goods being recognised in the incorrect period as a key audit matter.

We have performed the following principal audit procedures in relation

to revenue recognised which include a combination of testing internal

controls and substantive testing as under:

• Assessed the appropriateness of the Company's revenue recognition accounting policies in line with Ind AS 115 (“Revenue from Contracts with Customers") and testing thereof.

• Evaluated the integrity of the general information and technology ('IT') control environment and testing the operating effectiveness of key IT application controls.

• Understood the revenue recognition process, evaluating the design and implementation of Company's controls in respect of revenue cut-off at year-end.

• Tested the operating effectiveness of such controls over revenue cut off at year-end.

• Tested the supporting documentation for sales transactions recorded during the period closer to the year end and subsequent to the year end, including examination of credit notes issued after the year end to determine whether revenue was recognised in the correct period upon fulfillment of the performance obligations.

• Performed analytical procedures on current year revenue based on monthly trends and where appropriate, conducting further enquiries and testing.

Sr.

No.

Key Audit Matter

Auditor's Response

2

Assessment for impairment of Investment

We have performed the following principal audit procedures in relation

in subsidiary:

to assessment of impairment of investment in subsidiary, which include

The Company has investment of ' 27,895.67

a combination of testing internal controls and substantive testing as

million in Gland Pharma International Pte.

under:

Ltd., Singapore, a wholly-owned subsidiary,

• Obtained an understanding of the management's process for

which is carried at cost, subject to an

identification of impairment indicators.

assessment for impairment. (Refer Note 7 of

• Evaluated the design and implementation of the relevant controls

the Financial Statements)

and the operating effectiveness of such internal controls which

The Company has assessed the recoverable

inter-alia includes the completeness and accuracy of the input

amount of investment in the wholly-owned

data considered, reasonableness of the assumptions considered

subsidiary for impairment using the Value in

in determining the present value of future cash flows.

Use (ViU) approach.

• Obtained the business projections (prepared by the Management)

The determination of recoverable amount of

and performed the following procedures:

investment based on ViU, involves significant

(i)

Conducted inquiries with the Management to identify if

estimates and judgement in determining

factors that, in our professional judgement, should be taken

the assumptions such as revenue growth,

into account in the analysis were considered.

operating margins, and in determining the valuation assumptions relating to discount rates and long-term growth rate applied to

(ii)

Assessed the cash flow forecasts through analysis of actual past performance and comparison to previous forecasts.

estimate future cash flows.

(iii)

Verified if the cash flow projections considered for the

Impairment of investment has been

assessment of impairment were as per the cash flow

identified as a key audit matter due to:

projections reviewed and approved by the Board of Directors of the Company and that of the step down subsidiary.

• The significance of the carrying value of the investment; and

(iv)

Evaluated the Management's future cash flow projections, with regard to the appropriateness of key assumptions

• The assessment of the carrying value

considered, including discount rate, growth rate, sensitivity

involving assumptions and exercise of significant judgement in predicting future cash flow projections. Any adverse changes to this assumption could result in lower recoverable amount than the carrying amount.

(v)

analysis of the key assumptions etc. duly considering the historical accuracy of the Company's estimates in the prior period, and comparison of the assumptions with observable market data wherever available.

Involved our valuation specialists to review key assumptions considered in the ViU workings such as discount rate and

growth rate.


Information Other than the Financial Statements and Auditor's Report Thereon

• The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Directors' Report, Management Discussion & Analysis, Report on Corporate Governance and the Business Responsibility & Sustainability Report, but does not include the consolidated financial statements, standalone financial statements and our auditor's report thereon.

• Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

• In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained during the course of our audit or otherwise appears to be materially misstated.

• If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of Management and Board of Directors for the Standalone Financial Statements

The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the accounting principles generally accepted in India, including Ind AS specified under Section 133 of the Act. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that

are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, management and Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intend to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Company's Board of Directors is also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibility for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal financial controls relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the standalone financial statements may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the standalone financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal financial controls that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing

so would reasonably be expected to outweigh the public

interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our audit, we report that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books.

c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, Statement of Changes in Equity and the Statement of Cash Flows dealt with by this Report are in agreement with the books of account.

d) In our opinion, the aforesaid standalone financial statements comply with the Ind AS specified under Section 133 of the Act.

e) On the basis of the written representations received from the directors as on March 31, 2025 taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2025 from being appointed as a director in terms of Section 164(2) of the Act.

f) With respect to the adequacy of the internal financial controls with reference to standalone financial statements of the Company and the operating effectiveness of such controls, refer to our separate Report in “Annexure A". Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company's internal financial controls with reference to standalone financial statements.

g) With respect to the other matters to be included in the Auditor's Report in accordance with the requirements of Section 197(16) of the Act, as amended, in our opinion and to the best of our information and according to the explanations given to us, the remuneration paid/ provided by the Company to its directors during the year is in accordance with the provisions of Section 197 of the Act.

h) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its standalone financial statements - Refer Note 44b to the standalone financial statements;

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the Company.

iv. (a) The Management has represented that,

to the best of its knowledge and belief, other than as disclosed in the Note 49 to the standalone financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities (“Intermediaries"), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(b) The Management has represented, that, to the best of its knowledge and belief, no funds have been received by the Company from any person(s) or entity(ies), including foreign entities (“Funding Parties"), with the understanding, whether recorded in writing or otherwise, that the Company shall, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(c) Based on the audit procedures performed that have been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (i) and (ii) of Rule 11(e), as provided under (a) and (b) above, contain any material misstatement.

v. The final dividend proposed in the previous year, declared and paid by the Company during the year is in accordance with Section 123 of the Act, as applicable.

As stated in Note 17 to the standalone financial statements, the Board of Directors of the Company has proposed final dividend for the year which is subject to the approval of the members at the ensuing Annual General Meeting. Such dividend proposed is in accordance with Section 123 of the Act, as applicable.

vi. Based on our examination, which included test checks, the Company has used accounting software systems for maintaining its books of account for the financial year ended March 31, 2025 which have the feature of recording audit trail (edit log) facility and the same has operated throughout the year for all relevant transactions recorded in the software systems. Further, during the course of our audit we did not come across any instance of the audit trail feature being tampered with and the audit trail has been preserved by the Company as per the statutory requirements for record retention.

2. As required by the Companies (Auditor's Report) Order, 2020 (“the Order") issued by the Central Government

in terms of Section 143(11) of the Act, we give in “Annexure B" a statement on the matters specified in paragraphs 3 and 4 of the Order.

For Deloitte Haskins & Sells

Chartered Accountants (Firm's Registration Number: 008072S)

Monisha Parikh

Partner

Membership No. 047840 UDIN: 25047840BMRJUX4877

Place: Hyderabad Date: May 20, 2025


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by